Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinib.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
John J ArcaroliWells A Messersmith

Abstract

Dysregulation of the phosphoinositide 3-kinase (PI3K) and Src signaling pathways commonly occur in colorectal cancer. Mutations in the PIK3CA gene are associated with an increase in severity of disease and worse clinical outcomes. Elevated levels of Src have been identified in premalignant lesions and are suggested to play a central role in tumor progression. Because these pathways appear to enhance tumor growth and metastasis, molecularly targeted agents for both pathways are currently being evaluated in early-phase clinical trials. We used colorectal cancer cell lines and a patient-derived explant model to investigate the efficacy of saracatinib. Mutations in the PIK3CA were evaluated to examine the association between mutations in the PIK3CA gene and sensitivity to saracatinib. We have identified a subset of patients with a PIK3CA (exon 9 and 20) mutation with increased sensitivity to saracatinib. A novel 3' untranslated region (UTR) mutation was also shown to be associated with increased sensitivity to saracatinib and have a reduced affinity for miR-520a and miR-525a. Importantly, we show that Src inhibition reduces the interaction between Src and p85, subsequently decreasing Akt-dependent signaling. These results indicate ...Continue Reading

References

Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C A CartwrightW Eckhart
Jan 1, 1993·The Journal of Clinical Investigation·M S TalamontiG E Gallick
Jan 1, 1996·Annual Review of Cell and Developmental Biology·K Burridge, M Chrzanowska-Wodnicka
Feb 21, 1997·Cell·T F FrankeL C Cantley
Jan 1, 1997·Annual Review of Cell and Developmental Biology·S M Thomas, J S Brugge
May 16, 1998·Current Biology : CB·R T Peterson, S L Schreiber
Feb 13, 1999·Nature Genetics·R B IrbyT J Yeatman
Feb 23, 1999·The American Journal of Pathology·R V LloydB W Scheithauer
May 5, 2001·The Journal of Biological Chemistry·B D CuevasG B Mills
Jul 31, 2001·Biochimica Et Biophysica Acta·M D Schaller
Jun 1, 2002·Science·Lewis C Cantley
Jun 7, 2002·IUBMB Life·Christof R HauckDavid D Schlaepfer
Oct 9, 2002·Oncogene·Renae L MalekNorman H Lee
Jul 23, 2003·Trends in Pharmacological Sciences·Matthias P WymannMuriel Laffargue
Mar 16, 2004·Science·Yardena SamuelsVictor E Velculescu
Jun 2, 2004·Nature Reviews. Cancer·Timothy J Yeatman
Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sohye KangPeter K Vogt
Jul 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sérgia VelhoRaquel Seruca
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Belen Rubio-ViqueiraManuel Hidalgo
Jun 26, 2007·International Journal of Cancer. Journal International Du Cancer·Shunsuke KatoKenichi Sugihara
Dec 14, 2007·Nucleic Acids Research·Minoru KanehisaYoshihiro Yamanishi
Jan 29, 2008·International Journal of Cancer. Journal International Du Cancer·Ludovic BaraultFrancoise Piard
Apr 28, 2009·Molecular Oncology·Tim P GreenGerard F Costello
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·N V RajeshkumarManuel Hidalgo
Jul 4, 2009·Cancer Cell·Krishna M VasudevanLevi A Garraway
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Youji HeCorrie A M Marijnen
Jun 10, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Todd M PittsS Gail Eckhardt
Aug 5, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John J ArcaroliWells A Messersmith

❮ Previous
Next ❯

Citations

Nov 16, 2013·Journal of the National Cancer Institute·Shuji OginoUNKNOWN Alliance for Clinical Trials in Oncology
Nov 30, 2013·Omics : a Journal of Integrative Biology·Mayakannan Manikandan, Arasambattu Kannan Munirajan
Nov 19, 2013·Carcinogenesis·Katsuhiko NoshoYasuhisa Shinomura
Jul 3, 2013·Journal of Cancer Research and Clinical Oncology·Jitka MlcochovaOndrej Slaby
Jun 13, 2015·BioMed Research International·Jian WangYinxue Yang
Dec 3, 2014·Biochimica Et Biophysica Acta·Stine Aske DanielsenRagnhild A Lothe
Oct 5, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ali MohammadiBehzad Baradaran
Aug 17, 2017·International Journal of Molecular Sciences·Ali Mehdi, Yasser Riazalhosseini
Sep 21, 2013·Physiological Genomics·Paige E BennettYiqun G Shellman
Jul 25, 2018·World Journal of Gastroenterology : WJG·Kenneth Kw ToWilliam Cs Cho
Jul 28, 2019·Journal of Cellular Physiology·Fatemeh RafieeniaSeyed Hamid Aghaee-Bakhtiari
Jun 27, 2019·Journal of Cellular Biochemistry·Lingyu QiChanggang Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.